1. Build a Strong Employer BrandFirst up, let’s talk about your employer brand. Think of it as your company’s personality and reputation. In Japan’s competitive pharmaceutical and medical device industry, it’s crucial to stand out. You need to showcase your…
HOME > TOP STORIES
TOP STORIES
-
BUSINESS Takeda Initiates PIII Trial for Anticancer Agent Motesanib in Asia
July 27, 2012
-
ORGANIZATION EFPIA Submits Opinion Letter to MHLW Calling for Review of Priority Focus on Japanese Companies for Blood Plasma Products
July 27, 2012
-
BUSINESS Taiho Licenses Anti-Allergy Drug from Faes Farma in Japan
July 26, 2012
-
REGULATORY MHLW Asks Sanofi Pasteur to Consider Reducing Price of IPV
July 25, 2012
-
ORGANIZATION Hiroshima Wholesale FTC Sees “Gradual Effects” in Correcting Labor Services in Cooperation with Pharmacists
July 25, 2012
-
BUSINESS Confident of Posting Sales of 100 Billion Yen with 3 Focal Products Including Teribone: Asahi Kasei Pharma President Asano
July 24, 2012
-
BUSINESS HBM Taking Advantage of Avian Biotechnology for Antibody Drug Discovery: President Toyoura
July 23, 2012
-
BUSINESS Inlyta as Standard Drug in Second-Line Treatment: Pfizer
July 20, 2012
-
REGULATORY Cost-Effective Assessments to Be Limited to Technologies for Which Alternatives Are Available: CSIMC
July 19, 2012
-
BUSINESS China to Overtake Japan as Second-Biggest Drug Market by 2016: IMS Health
July 18, 2012
-
ORGANIZATION 4.5 Bil. Yen Tax Hike Estimated in FY2012 Tax Reform: JPMA
July 17, 2012
-
BUSINESS RIJ Plans World’s First Trial of iPS Cell Therapy in Men: President & CEO Kagimoto
July 16, 2012
-
ORGANIZATION Wholesaler FTC to Make Serious Efforts for Improving “Services of Convenience”
July 13, 2012
-
BUSINESS Teijin Pharma to Boost New Drug Ratio to More than 50%, Prepare “Post-Feburic” Products: President Arao
July 12, 2012
-
BUSINESS Suzuken to Offer Voluntary Early Retirement Program for Record 500 Employees
July 11, 2012
-
REGULATORY Health Minister Komiyama Takes Lead to Include Reference Price Systems in Policy-Screening Group’s Proposals
July 10, 2012
-
REGULATORY On-Site Strategy Consultations to Be Held in Kansai Region: MHLW
July 6, 2012
-
BUSINESS Nippon Kayaku Considers Promotional Measures for Biosimilars, Vascular Embolization Medical Devices
July 5, 2012
-
BUSINESS AZ to Promote Symbicort, SMART Therapy Targeting GPs, Specialists
July 5, 2012
-
BUSINESS 230 MSs of Mediceo Begin to Work as ARs for Sawai
July 4, 2012
ページ
In late January, a bill to amend the Pharmaceuticals and Medical Devices Act cleared key legislation review processes by the…
A Japanese health ministry panel on December 26 wrapped up its discussions on the next amendment of the Pharmaceuticals and…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s key reimbursement policy panel on December 25 approved an outline of the FY2025 drug price revision, finalizing plans to…
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…
A Japanese health ministry panel discussing the generic industry structure on May 22 put together a report in which it…
A Japanese health ministry study group focused on pharmaceutical regulations on March 21 agreed on a policy to encourage the…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…
The Japanese health ministry’s expert panel tasked to discuss comprehensive policies for the rapid and stable supply of pharmaceuticals generally…